FI951218A0 - Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä - Google Patents

Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä

Info

Publication number
FI951218A0
FI951218A0 FI951218A FI951218A FI951218A0 FI 951218 A0 FI951218 A0 FI 951218A0 FI 951218 A FI951218 A FI 951218A FI 951218 A FI951218 A FI 951218A FI 951218 A0 FI951218 A0 FI 951218A0
Authority
FI
Finland
Prior art keywords
cholesterol
low
density lipoprotein
blood levels
reducing blood
Prior art date
Application number
FI951218A
Other languages
English (en)
Swedish (sv)
Other versions
FI951218A (fi
Inventor
Steven L Nissen
Original Assignee
Univ Iowa State Res Found Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25484425&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI951218(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Iowa State Res Found Inc filed Critical Univ Iowa State Res Found Inc
Publication of FI951218A0 publication Critical patent/FI951218A0/fi
Publication of FI951218A publication Critical patent/FI951218A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI951218A 1992-09-16 1995-03-15 Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä FI951218A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US94640492A 1992-09-16 1992-09-16
PCT/US1993/008695 WO1994006417A1 (en) 1992-09-16 1993-09-15 Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol

Publications (2)

Publication Number Publication Date
FI951218A0 true FI951218A0 (fi) 1995-03-15
FI951218A FI951218A (fi) 1995-03-15

Family

ID=25484425

Family Applications (1)

Application Number Title Priority Date Filing Date
FI951218A FI951218A (fi) 1992-09-16 1995-03-15 Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä

Country Status (12)

Country Link
US (1) US5360613A (fi)
EP (1) EP0660706B1 (fi)
JP (1) JP3148243B2 (fi)
AU (1) AU673002B2 (fi)
BR (1) BR9307035A (fi)
CA (1) CA2142314C (fi)
DE (1) DE69327468T2 (fi)
ES (1) ES2142353T3 (fi)
FI (1) FI951218A (fi)
NO (1) NO951000D0 (fi)
NZ (1) NZ256300A (fi)
WO (1) WO1994006417A1 (fi)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756469A (en) * 1996-07-26 1998-05-26 Beale; Paxton K. Composition of pyruvate and anti-cortisol compounds and method for increasing protein concentration in a mammal
US5716926A (en) * 1996-07-26 1998-02-10 Paxton K. Beale Composition of pyruvate and protein and method for increasing protein concentration in a mammal
US6103764A (en) * 1997-11-07 2000-08-15 Iowa State University Research Foundation, Inc. Method for increasing the aerobic capacity of muscle
US6031000A (en) * 1998-06-23 2000-02-29 Iowa State University Research Foundation, Inc. Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
AU2620600A (en) * 1999-01-21 2000-08-07 Steroidogenesis Inhibitors International Composition of anti-hiv drugs and anti-cortisol compounds and method for decreasing the side effects of anti-hiv drugs in a human
DE50205794D1 (de) * 2001-05-18 2006-04-20 Lonza Ag Verfahren zur herstellung fester formulierungen von natrium-3-hydroxy-3-methylbutyrat
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040220266A1 (en) * 2002-09-09 2004-11-04 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
US6812249B2 (en) * 2003-03-04 2004-11-02 Sal Abraham Process for preparing a 3-hydroxy-3-methylbutyrate amino acid salt and method of use
WO2005096846A1 (en) * 2004-03-11 2005-10-20 Wiley Organics, Inc. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20050215640A1 (en) * 2004-03-26 2005-09-29 Baxter Jeffrey H HMB compositions and uses thereof
EP1973426A2 (en) * 2005-11-03 2008-10-01 Southwest Immunology Inc. Compositions for preventing and reducing delayed onset muscle soreness
WO2007075605A2 (en) 2005-12-19 2007-07-05 Abbott Laboratories Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type and type 2 cytokine production
US20080200422A1 (en) * 2007-01-09 2008-08-21 Cavener Douglas R Methods for reduction of adipose tissue mass
US9539224B2 (en) 2008-12-09 2017-01-10 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9259430B2 (en) 2008-12-09 2016-02-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US11173167B2 (en) 2008-12-09 2021-11-16 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9770424B2 (en) 2008-12-09 2017-09-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US8815280B2 (en) * 2008-12-09 2014-08-26 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US9707241B2 (en) 2008-12-09 2017-07-18 Metabolic Technologies, Inc. Nutritional intervention for improving muscular function and strength
US8538727B2 (en) * 2009-07-21 2013-09-17 George S. Cembrowski Method and apparatus for calibration and testing of scientific measurement equipment
US11042605B2 (en) 2009-07-21 2021-06-22 Ccqcc Corp. Method and apparatus for calibration and testing of scientific measurement equipment
IN2012DN06441A (fi) 2010-01-29 2015-10-09 Abbott Lab
US9693577B2 (en) 2010-01-29 2017-07-04 Abbott Laboratories Method of preparing a nutritional powder comprising spray dried HMB
ES2436890T3 (es) 2010-01-29 2014-01-07 Abbott Laboratories Líquidos nutricionales envasados asépticamente que comprenden HMB
TWI526161B (zh) 2010-06-10 2016-03-21 亞培公司 包含鈣ｈｍｂ及可溶性蛋白質之實質上透明營養液
KR20140054066A (ko) * 2011-07-15 2014-05-08 뉴서트 사이언시스, 인크. 대사 경로 조절을 위한 조성물 및 방법
BR112014003434A2 (pt) * 2011-08-15 2017-03-01 Abbott Lab processo para produção de hmb e seus sais
EP2773363A1 (en) 2011-11-03 2014-09-10 University of Florida Research Foundation, Inc. Nutritional supplement for weight management
WO2012140276A2 (en) * 2011-11-17 2012-10-18 Lonza Ltd Process for the preparation of 3-hydroxy-3-methylbutyric acid or its calcium salts
FI3733171T3 (fi) 2012-09-10 2024-01-24 Metabolic Tech Llc Koostumuksia sisältäen hmb:tä ja atp:tä sekä niiden käyttö
AU2015237273B2 (en) 2014-03-27 2020-06-18 Roland W. Winterfield Beta-hydroxy beta-methylbutyrate for alleviating statin myopathy
MX2018003289A (es) 2015-09-16 2018-11-09 Metabolic Tech Inc COMPOSICIONES Y METODOS DE USO DE ß-HIDROXI-ß-METILBUTIRATO (HMB) PARA AUMENTAR LA RECUPERACION DE TRAUMA DE TEJIDO BLANDO.
CN108473411B (zh) * 2015-11-19 2022-08-12 协和发酵生化株式会社 3-羟基异戊酸的一价阳离子盐的晶体及该晶体的制造方法
US10213399B2 (en) 2016-01-21 2019-02-26 Metabolic Technologies, Inc. Compositions and methods of use of β-hydroxy-β-methylbutyrate (HMB) for modulating autophagy and lipophagy
EP3476825A4 (en) 2016-06-24 2020-02-26 Kyowa Hakko Bio Co., Ltd. BETA-HYDROXY BETA-METHYLBUTYRIC ACID AMINO ACID SALT CRYSTAL AND METHOD FOR PRODUCING THE SAME
FI3528801T3 (fi) 2016-10-21 2024-10-24 Metabolic Tech Llc Beeta-hydroksi-beeta-metyylibutyraatin (hmb) ja probioottien koostumuksia ja menetelmiä niiden käyttämiseksi

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3629449A (en) * 1968-04-22 1971-12-21 Majid Siddiqi Process of combatting hypercholesterolemia
US4760090A (en) * 1986-03-11 1988-07-26 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to cattle and sheep
US4764531A (en) * 1986-03-11 1988-08-16 Iowa State University Research Foundation, Inc. Method of feeding ketoisocaproate to laying chickens
US5028440A (en) * 1990-01-30 1991-07-02 Iowa State University Research Foundation, Inc. Method of raising meat producing animals to increase lean tissue development
US5087472A (en) * 1990-01-30 1992-02-11 Iowa State University Research Foundation, Inc. Feed compositions for domestics animals containing hydroxymethylbutyrate
US4992470A (en) * 1990-02-08 1991-02-12 Iowa State University Research Foundation, Inc. Method of enhancing immune response of mammals

Also Published As

Publication number Publication date
AU4922593A (en) 1994-04-12
JP3148243B2 (ja) 2001-03-19
DE69327468D1 (de) 2000-02-03
ES2142353T3 (es) 2000-04-16
DE69327468T2 (de) 2000-05-11
AU673002B2 (en) 1996-10-24
NO951000L (no) 1995-03-15
NO951000D0 (no) 1995-03-15
US5360613A (en) 1994-11-01
WO1994006417A1 (en) 1994-03-31
EP0660706A4 (fi) 1995-07-26
EP0660706B1 (en) 1999-12-29
CA2142314A1 (en) 1994-03-31
JPH08501777A (ja) 1996-02-27
CA2142314C (en) 1999-06-01
BR9307035A (pt) 1999-06-29
NZ256300A (en) 1997-06-24
FI951218A (fi) 1995-03-15
EP0660706A1 (en) 1995-07-05

Similar Documents

Publication Publication Date Title
FI951218A0 (fi) Menetelmä kokonaiskolesterolin ja matalatiheyksisen lipoproteiinikolestrolin pitoisuuksien pienentämiseksi veressä
NO950774D0 (no) Fremgangsmåte for inhibering av bentap og nedsettelse av serumkolesterol
DK0594612T3 (da) Præparat til sænkning af cholesterolindholdet i serum og fremgangsmåde til fremstilling af præparater
FI971969A0 (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
PL315635A1 (en) Method of solubilising hardly pharmaceutically active substances
DE69505657D1 (de) Fluorcarbonetherhybriden enthaltende physiologich akzeptabele emulsionen und verwendungsverfahren
ATE251627T1 (de) Verfahren und kristallformen von 2- methylthienobenzodiazepinen
EE03966B1 (et) Valuvaigistava toimega ühendid ja nende valmistamise meetod
AU4995693A (en) Apparatus and method for the treatment of blood
EP0764848A4 (en) METHOD FOR QUANTIFYING CHOLESTEROL IN LOW DENSITY OR VERY LOW DENSITY LIPOPROTEIN
FI961374A (fi) Menetelmä ja laite ensisijaisten resurssirajoitusten yhdistämiseksi
FI964330A0 (fi) Menetelmä ja laite porrashissejä varten
EE9800234A (et) Ravimeetod ja farmatseutiline kompositsioon
EE03391B1 (et) Aminoetüületanoolamiini ja/või hüdroksüetüülpiperasiini saamise meetod
FI962629A (fi) Menetelmä ja laite massan jatkuvatoimiseksi keittämiseksi
FI96317C (fi) Menetelmä hienojakoisten ja muunnettujen tärkkelyksien valmistamiseksi
FI944294A (fi) Menetelmä ja laitteisto hissin toiminnan varmistamiseksi
EE9800164A (et) Farmatseutiline kompositsioon ja meetod epitelioomi raviks
EE03669B1 (et) Vedelad alendronaatpreparaadid ja nende valmistamismeetod
DE69328526D1 (de) Mittel zur Abschaffung oder Senkung des Blutcholesterols
FI970861A (fi) Menetelmä ja laitteisto syväporausten muotoon vaikuttamiseksi
ZA943203B (en) Method of lowering blood lipid levels
EP0431763A3 (en) Therapeutic agents for lowering triglyceride and/or cholesterol levels and/or increasing hdl levels
FI940396A (fi) Menetelmä kuormatilojen käsittelemiseksi ja kuormatilayhdistelmä
UA10998C2 (uk) Спосіб поліфакторhої лікувальhої дії та ковдра для поліфакторhої лікувальhої дії